Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 534-538

  Zhang, Yinxu ^a   Liu, Xiaomei ^a   Zuo, Teng ^a   Liu, Yu ^a   Zhang, Jun Hua ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer cells; Multidrug resistance; P glycoprotein; TMP

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOSINE TRIPHOSPHATASE; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN; TETRAMETHYLPYRAZINE; ANTINEOPLASTIC ANTIBIOTIC; GLYCOPROTEIN P; MESSENGER RNA; PYRAZINE DERIVATIVE; VASODILATOR AGENT;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ADENOSINE TRIPHOSPHATASES; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; P-GLYCOPROTEINS; PYRAZINES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASODILATOR AGENTS;

EID: 84866300414     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9950-8     Document Type: Article

References (8)

1. Szakács G, Paterson JK, Ludwig JA, et al. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5:219.
2. Nobili S, Landini I, Giglion B, et al. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets. 2006;7:861.
3. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55.
4. Dai CL, Liang YJ, Fu LW, et al. Sensitization of ABCB1 overexpression cells to chemotherapeutic agents by FG020326 via binding to ABCB1, inhibiting its function. Biochem Pharmacol. 2009;78:355.
5. Mistry P, Stewart AJ, Dangerfield W, et al. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res. 2001;61:749.
6. Fu LW, Zhang YM, Liang YJ, et al. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/dox cells. Eur J Cancer. 2002;38:418.
7. Zhou C, Shen P, Cheng Y. Quantitative study of the drug efflux kinetics from sensitive and MDR human breast cancer cells. Biochim Biophys Acta. 2007;1770:1011.
8. Wang XB, Wang SS, Zhang QF, et al. Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells. Oncol Rep. 2010;23:211.